Berlin, Germany

Grit Zahn

USPTO Granted Patents = 3 



Average Co-Inventor Count = 9.2

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Grit Zahn in Integrin Inhibition

Introduction

Grit Zahn is a prominent inventor based in Berlin, Germany, with a notable focus on developing compounds that inhibit integrins. With a total of three patents to her name, Zahn is dedicated to advancing medical therapies through her innovative research.

Latest Patents

Among her latest patents is the invention titled "Compounds for the Inhibition of Integrins and Use Thereof." This patent focuses on a compound of a specific formula where A is a nonaromatic heterocyclic ring, Ar may be phenylene, and other various radical components are included. These compounds serve as integrin inhibitors, particularly targeting the fibronectin receptor alpha5beta1, making them vital for anti-angiogenic therapies.

Another of her significant patents is "Compounds for the Inhibition of Angiogenesis and Use Thereof." This invention details a different structural approach to integrin inhibition, aimed at treating diseases where angiogenesis inhibition is desired. These therapeutic compounds hold great promise for medical applications in various disease contexts.

Career Highlights

Grit Zahn is currently affiliated with Shire Orphan Therapies GmbH, a company that specializes in developing therapies for rare diseases. Her work has propelled significant advancements in the field of pharmacology, particularly in the treatment of conditions that involve abnormal blood vessel formation.

Collaborations

Throughout her career, Grit Zahn has collaborated with notable colleagues such as Gunther Zischinsky and Roland Stragies. These partnerships enhance her research capabilities and contribute to the innovative environment at Shire Orphan Therapies.

Conclusion

Grit Zahn's commitment to innovation in integrin inhibition exemplifies the vital role of inventors in advancing medical science. Her latest patents demonstrate her dedication to developing targeted therapies that have the potential to improve patient outcomes. As she continues her work in the field, Zahn's contributions will undoubtedly make a lasting impact on medical therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…